Exposure to anesthetic gases and Parkinson’s disease: a case report

详细信息    查看全文

• 作者：Giuseppe Mastrangelo (1)
  Vera Comiati (1)
  Massimiliano dell’Aquila (2)
  Emanuele Zamprogno (1)
  
• 关键词：Parkinson’s disease ; Anesthetic gases ; Nitrous oxide ; Halothane ; Isoflurane ; Levoflurane ; Occupational disease ; Causality
• 刊名：BMC Neurology
• 出版年：2013
• 出版时间：December 2013
• 年：2013
• 卷：13
• 期：1
• 全文大小：165 KB
• 参考文献：1. Trevisan A, Gori GP: Biological monitoring of nitrous oxide exposure in surgical areas. / Am J Ind Med 1990, 17:357-62. CrossRef
  2. Lanzi C, Caberlotto F, Marcuzzo G, Scapellato ML, Saia B, Bartolucci GB: Monitoraggio dell’esposizione a gas anestetici. In / Atti 62 Congresso Nazionale della Società Italiana di Medicina del Lavoro e Igiene Industriale: 29 Set -2 Ott 1999. Genova: Edizioni ECIG; 1999:299-03.
  3. Scapellato ML, Marcuzzo G, Focella G, Bitozzi A, Barbirato P, Gori G, Zanetti C, Bartoluzzi GB: Monitoraggio biologico dell’esposizione a gas anestetici. / Archivio Scienze Lavoro 1994, 10:369-72.
  4. Tuggle RM: Assessment of occupational exposure using one-sided tolerance limits. / Am Ind Hyg Assoc J 1982, 43:338-46. CrossRef
  5. Zorzon M, Capus L, Pellegrino A, Cazzato G, Zivadinov R: Familial and environmental risk factors in Parkinson’s disease: a case–control study in north-east Italy. / Acta Neurol Scand 2002, 105:77-2. CrossRef
  6. Peretz C, Alexander BH, Nagahama SI, Domino KB, Checkoway H: Parkinson’s disease mortality among male anesthesiologists and internists. / Mov Disord 2005, 20:1614-617. CrossRef
  7. Brodsky JB: Exposure to anesthetic gases: a controversy. / AORN J 1983, 38:132-44. CrossRef
  8. Guéant JL, Alpers DH: Vitamin B12, a fascinating micronutrient, which influences human health in the very early and later stages of life. / Biochimie 2013, 95:967-69. CrossRef
  9. Krajewski W, Kucharska M, Pilacik B, Fobker M, Stetkiewicz J, Nofer JR, Wronska-Nofer T: Impaired vitamin B12 metabolic status in healthcare workers occupationally exposed to nitrous oxide. / Brit J Anesth 2007, 99:812-18. CrossRef
  10. McCaddon A: Vitamin B12 in neurology and ageing; clinical and genetic aspects. / Biochimie 2013, 95:1066-076. CrossRef
  11. Orozco-Barrios CE, Battaglia-Hsu SF, Arango-Rodriguez ML, Ayala-Davila J, Chery C, Alberto JM, Schroeder H, Daval JL, Martinez-Fong D, Gueant JL: Vitamin B12-impaired metabolism produces apoptosis and Parkinson phenotype in rats expressing the transcobalamin-oleosin chimera in substantia nigra. / PLoS One 2009, 4:e8268. CrossRef
  12. Shahabi HN, Andersson DR: Cytochrome P450 2E1 in the substantia nigra: relevance for dopaminergic neurotransmission and free radical production. / Synapse 2008, 62:379-88. CrossRef
  13. Votaw J, Byas-Smith M, Hua J, Voll R, Martarello L, Levey AI, Bowman FD, Goodman M: Interaction of isoflurane with the dopamine transporter. / Anesthesiology 2003, 98:404-11. CrossRef
  14. Tsukada H, Nishiyama S, Kakiuchi T, Ohba H, Sato K, Harada N, Nakanishi S: Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain. / Brain Res 1999, 849:85-6. CrossRef
  15. Cristóv?o AC, Choi DH, Baltazar G, Beal MF, Kim YS: The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. / Antioxid Redox Signal 2009, 11:2105-118. CrossRef
  16. Graham DG: Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. / Mol Pharmacol 1978, 14:633-43.
  17. Wu X, Lu Y, Dong Y, Zhang G, Zhang Y, Xu Z, Culley DJ, Crosby G, Marcantonio ER, Tanzi RE, Xie Z: The inhalation anesthetic isoflurane increases levels of proinflammatory TNF-α, IL-6, and IL-1β. / Neurobiol Aging 2012, 33:1364-378. CrossRef
  18. Picconi B, Piccoli G, Calabresi P: Synaptic Dysfunction in Parkinson’s Disease. In / Synaptic Plasticity. Edited by: Kreutz MR, Sala C. Vienna: Springer; 2012:553-72. CrossRef
  19. Lu Q, Ding K, Frosch MP, Jones S, Wolfe M, Xia W, Lanford GW: Alzheimer’s disease-linked presenilin mutation (PS1M146L) induces filamin expression and γ-secretase independent redistribution. / J Alzheimers Dis 2010, 22:235-45.
  20. Dong Y, Wu X, Zhang G, Xu Z, Zhang Y, Gautam V, Kovacs DM, Wu A, Yue Y, Xie Z: Isoflurane facilitates synaptic NMDA receptor endocytosis in mice primary neurons. / Curr Mol Med 2012, 13:488-98. CrossRef
  21. Eckenhoff RG, Johansson JS, Wei H, Carnini A, Kang B, Wei W, Pidikiti R, Keller JM, Eckenhoff MF: Inhaled anesthetic enhancement of amyloid-β oligomerization and cytotoxicity. / Anesthesiology 2004, 101:703-09. CrossRef
  22. Sugaya T, Kitani Y: Isoflurane reduces microtubule-associated protein 2 degradation compared with halothane during forebrain ischaemia in the rat. / Brit J Anesth 1993, 71:247-52. CrossRef
  23. Craddock TJA, St George M, Freedman H, Barakat KH, Damaraju S, Hameroff S, Tuszynski JA: Computational predictions of volatile anesthetic interactions with the microtubule cytoskeleton: implications for side effects of general anesthesia. / PLoS One 2012, 7:e37251. CrossRef
  24. Yue QX, Liu X, Guo DA: Microtubule-binding natural products for cancer therapy. / Planta Med 2010, 76:1037-043. CrossRef
  25. Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A: Meta-analysis of early nonmotor features and risk factors for Parkinson disease. / Ann Neurol 2012, 72:893-01. CrossRef
  26. Becker C, Jick SS, Meier CR: Use of antihypertensives and the risk of Parkinson disease. / Neurology 2008, 70:1438-444. CrossRef
  27. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2377/13/194/prepub
  
• 作者单位：Giuseppe Mastrangelo (1)
  Vera Comiati (1)
  Massimiliano dell’Aquila (2)
  Emanuele Zamprogno (1)
  
  1. Department of Molecular Medicine, Padua University, Padua, Italy
  2. Department of Anatomical, Histological, Medico-Legal and Locomotor Sciences, La Sapienza University, Rome, Italy
  
• ISSN：1471-2377

文摘

Background The administration of anesthetics determines depression of the central nervous system and general anesthesia by inhalation may cause an environmental pollution of the operating rooms. It may therefore conceive a possible occupational etiology of Parkinson's Disease (PD). Case presentation In a Caucasian male aged 59 years, PD was diagnosed by brain scans with a presynaptic radioactive tracer of the dopaminergic system. Family history was negative for Parkinson’s disease or essential tremor. He was a smoker, a moderate consumer of coffee and alcohol, and never exposed to pesticides/metals. For 30 years (since the age of 29 until today), he worked as an anesthesiologist in private clinics in the Veneto (Northern Italy), exposed to anesthetic gases. The time elapsed from first exposure to onset of disease is 22 years, fulfilling the requirement of the induction/latency period. A literature search demonstrated unacceptable levels of anesthetic gases in public hospitals of the Veneto region from 1990 to 1999. This exposure was presumably high also in private hospitals of the region until at least 2007, when an overexposure to sevoflurane was repeatedly measured in this patient. The association between occupational exposure to anesthetic gases and risk of Parkinson’s disease was supported by a case-control study (reporting a two-fold increase in the risk of PD associated with a clinical history of general anesthesia) and a cohort study comparing mortality from PD between US anesthesiologists and internists (showing a statistically significant excess (p=0.01) in anesthesiologists compared to internists). Numerous recent mechanistic studies (in vitro essays and in vivo short-term studies) strengthened the association between exposure to anesthetic gases (nitrous oxide, halothane, isoflurane, levoflurane) and PD. Conclusion In view of the limited evidence of human studies and the sufficient evidence of experimental studies, the high exposure to anesthetic gases could have induced PD in the subject under study.